In the first half of this year, investment in the pharmaceutical manufacturing industry increased, and the pharmaceutical industry is facing transformation and upgrading.

According to the National Bureau of Statistics, china's fixed asset investment (excluding farmers) sat out 2816.03 billion yuan in The January-June period, down 3.1% year-on-year, according to the National Bureau of Statisticsand the pharmaceutical manufacturing industry bucked the trend, up 13.6% year-on-yearaccording to incomplete statistics, so far, Shandong, Sichuan, Fujian, Hunan, Yunnan, Guizhou, Jilin, Guangdong, Zhejiang, Anhui, Hubei, Chongqing, Shanxi, Tianjin, Gansu and other at least 26 provinces and cities published their first half economic operation datafrom the data of these provinces and cities, most provinces and cities in the first half of fixed assets have increased, and most of the investment in the pharmaceutical manufacturing industry significantly increasedindustry believes that since this year, with the volume of procurement, health care investment, as well as the expansion of medical consumer demand, the pharmaceutical industry is facing capacity upgrades, pharmaceutical companies need to increase production capacity to meet market demandthe first half of the year, while more fixed investment to join the pharmaceutical industry to help the pharmaceutical industry industry development, pharmaceutical equipment investment will increase accordingly, the industry is facing transformation and upgradingPharmaceutical Equipment (Source: Pharmaceutical Network) in the first half of the year, investment in the multi-local pharmaceutical industry increased from the data published in the first half of the economic operation in many places, the pharmaceutical industry investment significantly increasedfor example, in the first half of this year, Guangdong's fixed asset investment grew by 0.1% year-on-year, up 15.4 percentage points from the first quarterinvestment in the production-related industries of epidemic prevention materials increased, with the pharmaceutical manufacturing industry, medical equipment and instrumentation manufacturing industry increasing by 50.3% and 25.5% respectively, pushing the decline in high-tech manufacturing industry to 21.1 percentage points lower than in the first quarterShanxi Province's fixed asset investment grew by 8.3% in the first half of the year, 11.4 percentage points faster than the national (-3.1%)the rapid growth of investment in manufacturing, especially equipment manufacturing, industrial investment in the province grew by 12.0%, 3.7 percentage points faster than the province's investment, investment in manufacturing grew by 11.9%, while investment in the pharmaceutical industry grew by 14.2%, significantly faster than that of the provinceShandong Province's fixed asset investment grew 1.3% year-on-year in the first half of the year, up 1.1 percentage points from January-May and 5.4 percentage points higher than in the first quarterinvestment in the area of people's livelihood protection accelerated significantly, with investment in the pharmaceutical manufacturing industry increasing by 30.5%in the eyes of industry veterans, this year in the special circumstances, the pharmaceutical sector eye-catching, by the capital market's high attention, access to many investment opportunitiesthe first half of the year, in 28 Shenwan first-class industries, biopharmaceutical growth reached nearly 40%, ranking first in all industries at present, the industry is generally optimistic about the long-term development of the pharmaceutical industry, think that medicine as a new need, in the aging process of population accelerated, consumption upgrade background, the pharmaceutical industry market prospects are broad pharmaceutical equipment industry is facing transformation and upgrading at present, under the influence of the policy of volume procurement, consistency evaluation, new health insurance, the pharmaceutical industry pattern has changed, pharmaceutical enterprises are facing new demandsuch as capacity upgrading, the industry is expected to usher in geometric growth of the domestic pharmaceutical equipment industry and the technical level of pharmaceutical equipment determines the level of pharmaceutical, so pharmaceutical equipment enterprises in the face of opportunities at the same time also need to meet the challenges of transformation and upgrading, need to continuously strengthen research and development investment, and continue to innovate technology understand that, in general, pharmaceutical equipment enterprises in the process of transformation and upgrading, research and development strength, can not meet the requirements of low-end equipment will gradually be eliminated, the need to develop and produce new equipment, which can not be separated from technology, design, services and other aspects of continuous investment in the current background of rising api, labor costs, pharmaceutical machine enterprises, especially small and medium-sized enterprises in the equipment research and development investment there is no doubt there is a certain pressure in recent years, large pharmaceutical equipment companies in research and development costs have maintained an increase in investment for example, in 2019, Dongfulong's research and development expenses increased by 21.81 percent year-on-year, and the annual research and development expenses accounted for 5.26 percent of revenue, also up year-on-year the first quarter of 2020, Dongfulong's research and development costs continued to be highly invested, up 37.76 percent year-on-year by the end of 2019, the company has 428 research and development personnel, accounting for 17.42% of the total number of employees, accounting for 2.85 percentage points over the previous year unique, in 2019, Chutian Technology's research and development costs of 178 million yuan, an increase of 23.54 percent year-on-year, the same period of research and development investment accounted for 9.51 percent of operating income the first half of 2020, as more fixed investment into the pharmaceutical industry to help the pharmaceutical industry industry, upstream pharmaceutical equipment investment will increase accordingly is conducive to encouraging enterprises, including small and medium-sized pharmaceutical machine enterprises, to increase investment in research and development, accelerate industrial transformation and upgrading, to meet the needs of the pharmaceutical industry for the future of the pharmaceutical equipment industry, some drug makers expressed optimism about the pharmaceutical equipment industry " many pharmaceutical favorable policies to promote the development of China's innovative pharmaceutical industry prospects, pharmaceutical equipment enterprises in the face of major consolidation, the elimination of low value-added backward equipment at the same time, but also can embrace a lot of opportunities, market competition will intensify and with the continued return of overseas elites in the pharmaceutical industry, more talent flow, pharmaceutical equipment into the general trend, the industry ushered in new requirements "